Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ecrisens
- Development stage
- Unknown
- Lead developer
- Prospera Biotech
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Ecrisens is a neurodermatological gel-cream developed by Prospera Biotech for the management of excessive sweating (hyperhidrosis). Unlike traditional antiperspirants that physically block pores, Ecrisens utilizes a combination of neuromodulatory ingredients to regulate the activity of eccrine glands. The product is designed for topical application on areas such as the armpits, hands, feet, and face, and is intended to provide progressive results over continuous use without interfering with the body's thermoregulatory requirements. It is marketed as a cosmetic/neurodermatological preparation rather than a pharmaceutical drug.
- Brand names
- Ecrisens
Beyond the preview
Go deeper on Ecrisens.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ecrisens.